|
Gyrasol Technologies, based in Lawrence, KS, was formed in 2007 to meet biopharmaceutical researchers' urgent need for expertly designed drug selection assay technologies. We have discovered and developed a novel sensor that enables the simultaneous monitoring of a variety of post-translational modifications in biological samples. We are now applying the technology to signaling-pathway profiling for diagnostics and personalized medicine applications.
MANAGEMENT
Susan K. Burgess, PhD, Founder, President and CEO, Chairman
Frauke Rininsland, PhD, Founder, CSO, Director
Timothy J.R. Harris, PhD, Founder
Lynda Wijcik, Director
Matthew McClorey, Director
Douglas Gaumer, Director
ADVISORS
Roger Brent, PhD
Charles Cantor, PhD
|
